Free Trial

Digital Health Acquisition (DHAC) Competitors

Digital Health Acquisition logo
$1.01 -0.11 (-9.42%)
As of 06/13/2025

DHAC vs. ENZ, BRTX, MGRX, OTRK, SSY, BGLC, VSEE, ACON, ATIP, and NIVF

Should you be buying Digital Health Acquisition stock or one of its competitors? The main competitors of Digital Health Acquisition include Enzo Biochem (ENZ), BioRestorative Therapies (BRTX), Mangoceuticals (MGRX), Ontrak (OTRK), SunLink Health Systems (SSY), BioNexus Gene Lab (BGLC), Vsee Health (VSEE), Aclarion (ACON), ATI Physical Therapy (ATIP), and NewGenIvf Group (NIVF). These companies are all part of the "healthcare" industry.

Digital Health Acquisition vs. Its Competitors

Digital Health Acquisition (NASDAQ:DHAC) and Enzo Biochem (NYSE:ENZ) are both small-cap services companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, community ranking, earnings, analyst recommendations and dividends.

1.0% of Digital Health Acquisition shares are owned by institutional investors. Comparatively, 36.9% of Enzo Biochem shares are owned by institutional investors. 6.6% of Digital Health Acquisition shares are owned by insiders. Comparatively, 11.4% of Enzo Biochem shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Digital Health Acquisition has higher earnings, but lower revenue than Enzo Biochem.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Digital Health AcquisitionN/AN/AN/AN/AN/A
Enzo Biochem$29.09M0.59-$26.08MN/AN/A

Enzo Biochem received 212 more outperform votes than Digital Health Acquisition when rated by MarketBeat users.

CompanyUnderperformOutperform
Digital Health AcquisitionN/AN/A
Enzo BiochemOutperform Votes
212
52.22%
Underperform Votes
194
47.78%

Digital Health Acquisition has a beta of 0.23, suggesting that its share price is 77% less volatile than the S&P 500. Comparatively, Enzo Biochem has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500.

In the previous week, Digital Health Acquisition's average media sentiment score of 0.00 equaled Enzo Biochem'saverage media sentiment score.

Company Overall Sentiment
Digital Health Acquisition Neutral
Enzo Biochem Neutral

Digital Health Acquisition has a net margin of 0.00% compared to Enzo Biochem's net margin of -75.34%. Digital Health Acquisition's return on equity of 0.00% beat Enzo Biochem's return on equity.

Company Net Margins Return on Equity Return on Assets
Digital Health AcquisitionN/A N/A N/A
Enzo Biochem -75.34%-7.96%-5.49%

Summary

Enzo Biochem beats Digital Health Acquisition on 5 of the 8 factors compared between the two stocks.

Get Digital Health Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for DHAC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DHAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DHAC vs. The Competition

MetricDigital Health AcquisitionHolding Offices IndustryServices SectorNASDAQ Exchange
Market Cap$3.64M$482.13M$3.04B$8.51B
Dividend YieldN/A7.68%0.33%4.15%
P/E RatioN/A2.507.8619.65
Price / SalesN/A80.1642.56152.18
Price / CashN/A69.01N/A34.64
Price / BookN/A6.280.204.59
Net IncomeN/A$35.76M-$4.34M$248.23M
7 Day Performance-11.40%2.39%-2.85%-1.07%
1 Month Performance-9.88%2.80%8.94%3.35%
1 Year Performance-92.99%45.25%13.06%13.77%

Digital Health Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DHAC
Digital Health Acquisition
N/A$1.01
-9.4%
N/A-92.3%$3.64MN/A0.002,021
ENZ
Enzo Biochem
N/A$0.33
-14.8%
N/A-71.2%$17.03M$29.09M0.00520Gap Down
High Trading Volume
BRTX
BioRestorative Therapies
3.9864 of 5 stars
$1.78
+0.6%
$18.00
+914.1%
-13.8%$13.28M$391K-1.167News Coverage
Gap Down
MGRX
Mangoceuticals
0.5111 of 5 stars
$2.09
-6.3%
N/A-97.4%$10.80M$511.08K-0.363Short Interest ↑
OTRK
Ontrak
2.5806 of 5 stars
$1.50
+2.0%
$45.00
+2,900.0%
-57.8%$6.33M$10.18M-0.14250
SSY
SunLink Health Systems
1.0714 of 5 stars
$0.88
-1.5%
N/A+22.8%$6.18M$31.09M6.261,376Negative News
Short Interest ↑
Gap Down
BGLC
BioNexus Gene Lab
0.3991 of 5 stars
$3.23
-1.7%
N/A-42.4%$5.79M$9.27M0.0030Gap Up
VSEE
Vsee Health
2.3344 of 5 stars
$1.13
+3.2%
$5.00
+344.4%
N/A$4.05M$6.38M0.00N/AGap Up
ACON
Aclarion
2.2081 of 5 stars
$6.73
+1.0%
$11,758.50
+174,747.6%
-99.7%$3.91M$54.60K0.007News Coverage
Short Interest ↓
ATIP
ATI Physical Therapy
0.2906 of 5 stars
$0.86
-4.4%
N/A-77.7%$3.79M$741.86M-0.055,600
NIVF
NewGenIvf Group
1.7831 of 5 stars
$2.88
-5.7%
N/A-99.2%$1.52M$5.43M0.00N/ANews Coverage
Gap Down

Related Companies and Tools


This page (NASDAQ:DHAC) was last updated on 6/14/2025 by MarketBeat.com Staff
From Our Partners